Elucidata Company
Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.
Technology:
Analytics, Artificial Intelligence, Biotechnology, Clinical Trials, Health Care, Life Science, Machine Learning, Software
Industry:
AI, Early Drug Development, United States
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2015-01-01
Employees Number:
51-100
Funding Status:
Early Stage Venture
Investors Number:
4
Total Funding:
23580000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-09-27
Last Funding Type:
Series A
Register and Claim Ownership